Place of Duloxetine in Concervative Treatment Women and Men with Stress Urinary Incontinence
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
History of introduction of duloxetine in medical practice, mechanism of action and using of duloxetine in concervative treatment women and men with stress urinary incontinence are shown. Modern structure of external urethral sphincter in women and men was shown with increasing of sphincter tone under duloxetine influence.
Duloxetine recommended by International Continent Society for initial treatment women with stress urinary incontinence but this drug gives only improvement of urine continence and quality of life with side effects. Duloxetine with connection with pelvic floor muscle training gives better results than using separately duloxetine and pelvic floor muscle training. Nausuea is the most frequency side symptom after using duloxetine. Results of own investigations were shown and indications for using duloxetine in women with stress urinary incontinence were summed up. The most positive results were obtained after combination of duloxetine with pelvic floor muscle training and electrostimulation of urethral sphincter. Duloxetine for treatment men with stress urinary incontinence after radical prostatectomy is only clinical tested. Estimation of efficacy of duloxetine in treatment men with stress urinary incontinence after open prostatectomy due to benign prostatic hyperplasia is needed.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Горовий В.І., Головенко В.П., Жук С.І. та ін. Шляхи підвищення ефективності лікування жінок із стресовим нетриманням сечі // Урологія. – 2006. – № 2. – С. 40–49.
Горовой В.И., Жук С.И., Головенко В.П., Кулаковская О.В. Использование препарата “Yentreve” (дулоксетин) в комплексном лечении женщин со стрессовым недержанием мочи // Здоровье женщины. – 2006. – № 4 (28). – С. 234–235.
Горовий В.І., Головенко В.П., Жук С.І. та ін. Застосування препарату Yentreve (дулоксетин) у комплексному лікуванні жінок із стресовим нетриманням сечі // Тези доповідей 5-го Українсько-Польського симпозіуму урологів. – Львів, 2007. – С. 66–67.
Горовий В.І., Жук С.І., Головенко В.П. та ін. Перший досвід застосування препарату Yentreve (дулоксетин) у комплексному лікуванні жінок із стресовим нетриманням сечі // Вісник Вінницького національного медичного університету. – 2007. – № 11 (2/1) – C. 675–677.
Горовий В.І., Яцина О.І. Анатомія стресового нетримання сечі у жінок // Здоров’я України. – 2019. – № 2–3(16–17). – С. 5–14.
Залобкова простатектомія в хірургічному лікуванні доброякісної гіперплазії простати / За ред. В.І. Горового, В.О. Шапринського, І.В. Барало, О.М. Капшука. – Вінниця: “Твори”, 2021. – 336 с.
Клінічна анатомія сечостатевих органів / За ред. Горового В.І., Шапринського В.О., Мазорчука Б.Ф. – Вінниця: Твори, 2016. – 640 с.
Мазо Е.Б., Иремашвили В.В. Дулоксетин – новое в фармакотерапии недержания мочи у женщин // Урология. – 2004. – № 6. – С. 57–59.
Нетримання сечі у жінок: навчальний посібник / За ред. Горового В.І., Яцини О.І. – Вінниця: ТОВ “ТВОРИ”, 2020. – 472 с.
Практична урогінекологія: курс лекцій / За ред. Горового В.І. – Вінниця: Вінницька обласна друкарня, 2015. – 728 с.
Хиць А. Стресове нетримання сечі: сучасна фармакологічна терапія // Укр. Мед. часопис. – 2020. – № 4 (138). – С. 1–4.
Abrams P., Artibani W. Understanding stress urinary incontinence. – Lier, Belgium: Ismar Healthcare, 2004. – 96 p.
Alan C., Eren A.E., Ersay A. et al. Efficacy of duloxetine in early management of urinary continence after radical prostatectomy // Current Urology. – 2014. – Vol. 8. – P. 43–48.
Basu M., Duckett J.R.A. Update on duloxetine for the management of stress urinary incontinence // Clinical Interventions in Aging. – 2009. – Vol. 4. – P. 25–30.
Bauer R.M., Gozzi C., Hubner W. et al. Comtemporary management of postprostatectomy incontinence // European Urology. – 2011. – Vol. 59. – P. 985–996.
Bump R.C., Voss S., Beardsworth A. et al. Long-term efficacy of duloxetine in women with stress urinary incontinence // BJU Int. – 2008. – Vol. 102. – P. 214–218.
Campbell-Walsh Urology / Wein A.J. et al. – 11th ed. – Philadelphia: Elsevier, 2016. – 4904 p.
Cardozo L., Lange R., Voss S. et al. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence // Curr. Med. Res. Opin. – 2010. – Vol. 26. – P. 253–261.
Chapple C.R. Duloxetine for male stress incontinence // European Urology. – 2004. – Vol. 49. – P. 958–960.
Cornu J-N., Merlet B., Ciofu C. et al. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomized, placebo-controlled trial // European Urology. – 2011. – Vol. 59. – P. 148–154.
Dmochowski R.R., Miklos J.R., Norton P.A. et al. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence // J. Urol. – 2003. – Vol. 170. – P. 1259–1263.
EAU Guidelines on urine incontinence / Burkhard F.C. et al. – EAU, 2020. – 99 p.
Erdinc A., Gurates B., Celik H. et al. The efficacy of venlafaxine in treatment of women with stress urinary incontinence // Arch. Gynecol. Obstet. – 2009. – Vol. 279. – P. 343–348.
Filocamo M.T., Marzi V.L., Popolo G.D. et al. Pharmacologic treatment in postprostatectomy stress urinary incontinence // Eur. Urol. – 2007. – Vol. 51. – P. 1559–1654.
Fink K.G., Huber J., Wurnschhimmel E., Smeller N.T. The use of Duloxetine in the treatment of male stress urinary incontinence // Wien Med. Wochenschr. – 2008. – Vol. 158. – P. 116–118.
Freeman R.M. Initial management urinary incontinence: pelvic floor muscle training and duloxetine // BJOG, 2006. – Vol. 113. (suppl. 1). – P. 10–16.
Ghoniem G.M., Vanleeuwen J.S., Elser D.M. et al. A randomized, controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence // J. Urol. – 2005. – Vol. 173. – P. 1647–1653.
Hagovska M., Svihra J. Evaluation of duloxetine and innovative pelvic floor muscle training in women with stress urinary incontinence (DULOXING) // Medicine. – 2020. – Vol. 99. – P. 1–6.
Haylen B.T., Ridder D., Freeman R.M. et al. An International Urogynecological Association (IUGA) / International Continence Society (ICS) join report on the terminology for female pelvic floor dysfunction // Neurourology and Urodynamics. – 2010. – Vol. 29. – P. 4–20.
Incontinence / Albrams P. et al. – 6th ed. – ICS – ICUD, 2017. – 2336 p.
Juneau A.D., Gomelsky A. Pharmaceutical options for stress urinary incontinence // Current Bladder Dysfunction Reports. – 2019. – Vol. 14. – P. 357–364.
Kim J.C., Cho K.J. Current trends in the management of post-prostatectomy incontinence // Korean Journal of Urology. – 2012. – Vol. 53. – P. 511–518.
Kotecha P., Sahai A., Malde S. Use of duloxetine for postprostatectomy stress urinary incontinence: a systematic review // European Urology Focus. – 2020 /10.1016/j.euf.2020.06.007
Lin A. T-L., Sun M-J., Tai A-L. et al. Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial // BMC Urology – 2008. – Vol. 8. – P. 2–9.
Li J., Yang L., Pu C. et al. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis // Int. Urol. Nephrol. – 2013. – Vol. 45. – P. 679–686.
Lukacz E.S., Santiago-Lastra Y., Albo M.E., Brubaker L. Urinary incontinence in women. A review // JAMA. – 2017. – Vol. 318. – P. 1592–1604.
Mariappan P., Alhasso A., Ballantyne Z. et al. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for treatment of stress urinary incontinence: a systematic review // Eur. Urol. – 2007. – Vol. 51. – P. 67–74.
Mariappan P., Alhasso A.A., Grant A., N`Dоw J.M.D. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults // Cochrane Library, Cohrane Database of Systematic Reviews. – 2010. – 3 p.
Maund E., Guski L.S., Gotzsche P.C. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports // CMAJ. – 2017. – Vol. 189. – P. 194–203.
Mihaylova B., Pitman R., Tincello et al. Cost-effectiveness of duloxetine: the stress urinary incontinence treatment (SUIT) study // International Society for Pharmacoeconimics and Outcomes Research (ISPOR). – 2010. – Vol. 13. – P. 565–572.
Millard R.J., Moore K., Rencken R. et al. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trials // BJU Int. – 2004. – Vol. 93. – P. 311–318.
Neff B., Guie A., Guralnick M.L. et al. Duloxetine for treatment of post-prostatectomy stress urinary incontinence // Can. Urol. Asoc. – 2013. – Vol. 7. – P. E260–262.
Niiti V.W. Duloxetine: a new pharmacologic therapy for stress urinary incontinence // Rev. Urol. – 2004. – Vol. 6 (suppl. 3). – P. 48–55.
Norton P.A., Zinner N.R., Yalcin I. et al. Duloxetine versus placebo in the treatment of stress urinary incontinence // American Journal of Obstetrics and Gynecology. – 2002. – Vol. 187. – P. 40–48.
Schlenker B., Gratzke C., Reich O. et al. Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy // Eur. Urol. – 2006. – Vol. 49. – P. 1075–1080.
Serra A.C., Rubio-Briones J., Payas M.P. et al. Postprostatectomy established stress urinary incontinence treated with duloxetine // Urology. – 2011. – Vol. 78. – P. 261–266.
Steers W.D., Herschorn S., Kreder K.J. et al. Duloxetine compared with placebo for treatment women with symptoms of overactive bladder // BJU Int. – 2007. – Vol. 100. – P. 337–345.
Sweeney D.D., Chancellor M.B. Treatment of stress urinary incontinence with duloxetine hydrochloride // Reviews in Urology. – 2005. – Vol. 7. – P. 81–86.
Textbook of female urology and urogynaecology / Cardozo L., Staskin D. – 3rd ed. – Informa Healthcare. – 2010. – 1384 p.
Tubaro A., Nunzio C. The current role of open surgery in BPH // EAU-EBU update series. – 2006. – Vol. 4. – P. 191–201.
Urogynecology and reconstructive pelvic surgery / Walters M.D., Karram M.M. – 4th ed. – Philadelphia: Mosby Elsevier, 2015. – 686 р.
Wallner C., Dabhoiwala N.F., DeRuiter M.C., Lamers W.H. The anatomical components of urinary incontinence // Eur. Urol. – 2009. – Vol. 55. – P. 932–944.
Walz J., Epstein J.I., Ganzer R. A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimization of cancer contval and preservation of continence and erection in candidates for radical prostatectomy: An update // Eur. Urol. – 2016. – Vol. 70. – P. 306–311.
Weinstein D., Cohen J.S., Liu S. et al. Duloxetine in rte treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic population // Current Medical Research and Opinion. – 2006. – Vol. 22. – P. 2121–2129.
Van Kerrebroeck P., Abrams P., Lange R. et al. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence // BJOG. – 2004. – Vol. 111 – P. 249–257.
Van Leeuwen J.H.S., Lange R.R., Jonasson A.F. et al. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence // Maturitas. – 2008. – Vol. 60. – P. 138–147.
Viktrup L., Yalcin I. Duloxetine treatment of stress urinary incontinence in women: effects of demographics, ooesity, chronic lung desease, hypoestrogenism, diabetes mellitus, and depression on efficacy // European Journal of Obstetrics & Gynecology and Reproductive Biology. – 2007. – Vol. 133. – P. 105–113.
Zahariou A., Papaioannou P., Kalоgirou G. Is HCL duloxetine effective in the management in urinary stress incontinence after radical prostatectomy // Urol. Int. – 2006. – Vol. 77. – P. 9–12.
Zinner N.R. Stress urinary incontinence in women: effiency and safety of duloxetine // European Urology Supplements. – 2005. – Vol. 4, issue 1. – P. 29–37.
